JJ, P., N, M., S, B., JM, C., & JS, L. (2024). Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases. Dermatologic clinics, 42(3), 481. https://doi.org/10.1016/j.det.2024.02.012
Chicago Style (17th ed.) CitationJJ, Pach, Mbonu N, Bhullar S, Cohen JM, and Leventhal JS. "Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases." Dermatologic Clinics 42, no. 3 (2024): 481. https://doi.org/10.1016/j.det.2024.02.012.
MLA (9th ed.) CitationJJ, Pach, et al. "Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases." Dermatologic Clinics, vol. 42, no. 3, 2024, p. 481, https://doi.org/10.1016/j.det.2024.02.012.
Warning: These citations may not always be 100% accurate.